Abstract

The goal of every obstetrician should be to give the best prenatal care to the fetus to achieve optimal perinatal outcome. The early assessment of patient specific risks of pregnancy complication has the purpose to improve pregnancy outcome. The first trimester and second trimester Screening tests have high predictive value for adverse pregnancy outcomes. Women should be adequately counseled for the disorders to be screened. Estimation of serum markers has vital role in counselling women and consideration of increased fetal surveillance. With innovations like serum markers obstetricians have the opportunity to improve pregnancy outcomes with effective treatment.

• 1.   Patil A, Jagtap A, Sanap S. Role of Alpha Fetoprotein in obstetrics. Indian J Matern Fetal Neonatal Med. 2021 Jan-Jun;8(1).
• 2.   Krantz D, Hallahan T, et al. Maternal serum screening markers and adverse outcomes: A new perspective. J Clin Med. 2014;3:693-712.
• 3.   Bouariu A, Panaitescu AM, et al. First trimester prediction of adverse pregnancy outcomes—Identify pregnancies at risk from as early as 11-13 weeks. Medicina (Kaunas). 2022 Feb 22;58(3):332.
• 4.   Ozgen G, Adanas G, et al. The predictive value of maternal serum screening tests for adverse pregnancy outcomes. Ann Med Res. 2020;27(4):1268-74.
• 5.   Seshadri L, Arjun G. Prenatal screening, prenatal diagnosis and fetal therapy. Walters Kluwer; 2017.
• 6.   Kumar P, Ruprai RK. Early pregnancy Assessment. In: Krishna U, Shah DS, Salvi V, Sheriar N, Damani K, editors. Pregnancy At Risk. 5th ed. Delhi: Jaypee Brothers Medical Publishers; 2017.
• 7.   Betz D, Fane K. Human Chorionic Gonadotropin [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Aug 8 [cited 2026 Jan 29]. Matsuzono T, Kou KO, et al. Abnormal First trimester Maternal serum biochemical Markers and Prediction of Adverse pregnancy outcomes. Hong Kong J Gynaecol Obstet Midwifery. 2015;15(2):100-5.
• 8.   Long W, Zhou Q, et al. Second–trimester Maternal serum screening bio-markers in the risk assessment for Preeclampsia. Ann Clin Lab Sci. 2018 May;48(3):308-13.
• 9.   Salhan S, Gupta A, Ganeshan I. Diagnosis of pregnancy. In: Salhan S, editor. Textbook of Obstetrics. 2nd ed. Delhi: Jaypee Brothers Medical Publishers; 2016.
• 10.   Yeu CY, Zhang CY, et al. Are serum levels of Inhibin A in second trimester predictors of adverse pregnancy outcomes? PLoS One. 2020 May 21;15(5):e0232634.
• 11.   Pureandarey H, Chakraborty A. Role of genetic investigations and counselling. In: Krishnan U, editor. High risk pregnancy. 5th ed. Delhi: Jaypee Brothers Medical Publishers; 2017.
• 12.   Sonek JD. First trimester screening and diagnosis of fetal defects. Current Progress in Obstetrics and Gynaecology. Vol 1.
• 13.   Macer DRJ. Ethics and Prenatal diagnosis. In: Milunsky A, editor. Genetic disorders and the fetus: Diagnosis, prevention and treatment. Baltimore: Johns Hopkins University Press; 1998.

Data Sharing Statement

Funding